Old Web
English
Sign In
Acemap
>
authorDetail
>
Kimberly Kaberle
Kimberly Kaberle
Cetuximab
Colorectal cancer
Vemurafenib
Blockade
Mutant
2
Papers
158
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406).
2017
Journal of Clinical Oncology
Scott Kopetz
Shannon McDonough
Van Karlyle Morris
Heinz Josef Lenz
Anthony M. Magliocco
Chloe E. Atreya
Luis A. Diaz
Carmen J. Allegra
Stephen E. Wang
Christopher H. Lieu
S. Gail Eckhardt
Thomas J. Semrad
Kimberly Kaberle
Katherine A. Guthrie
Howard S. Hochster
Show All
Source
Cite
Save
Citations (152)
S1406: Randomized phase II study of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (mCRC).
2015
Journal of Clinical Oncology
Scott Kopetz
Shannon McDonough
Van Karlyle Morris
Heinz-Josef Lenz
Anthony M. Magliocco
Chloe Evelyn Atreya
Luis A. Diaz
Carmen J. Allegra
Christopher Hanyoung Lieu
S. Gail Eckhardt
Thomas J. Semrad
Kimberly Kaberle
Katherine A. Guthrie
Howard S. Hochster
Show All
Source
Cite
Save
Citations (6)
1